The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis
Intraocular lymphomas (i-OL) are rare and aggressive subsets of primary cerebral tumors. Little is known about the pathogenesis. This is explained by the scarcity of patients and the tiny amount of ocular fluid sampled for biological analyses. In most cases, i-OL is misdiagnosed because its clinical features can mimic other ocular conditions. To date, no independent biological tool is able to firmly diagnose i-OL; the combination of cytologic examination, immunochemistry, flow cytometry, and molecular analysis is required.
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.